Fosrenol Disease Interactions
There are 2 disease interactions with Fosrenol (lanthanum carbonate).
Lanthanum carbonate (applies to Fosrenol) bowel obstruction
Major Potential Hazard, Moderate plausibility. Applicable conditions: Gastrointestinal Obstruction
The use of lanthanum carbonate is contraindicated in patients with bowel obstruction, including ileus and fecal impaction.
Lanthanum carbonate (applies to Fosrenol) gastrointestinal disease
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Gastrointestinal Diverticula, Gastroparesis, Gastrointestinal Perforation, History - Peptic Ulcer
Serious cases of gastrointestinal obstruction and perforation have been reported in patients taking lanthanum, some requiring surgery and hospitalization. Risk factors identified from post marketing reports include altered gastrointestinal anatomy (diverticular disease, peritonitis, history of GI surgery, ulceration or cancer), hypomotility disorders, and some concomitant medications as calcium channel blockers. However, some cases have also been reported in patients with no history of gastrointestinal disease. Lanthanum should be used cautiously in patients with gastrointestinal disease.
Switch to professional interaction data
Fosrenol drug interactions
There are 85 drug interactions with Fosrenol (lanthanum carbonate).
Fosrenol alcohol/food interactions
There is 1 alcohol/food interaction with Fosrenol (lanthanum carbonate).
Report options
More about Fosrenol (lanthanum carbonate)
- Fosrenol consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: phosphate binders
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Carafate
Carafate is an anti-ulcer medication used to treat active duodenal ulcers. Learn about side ...
Renvela
Renvela (sevelamer) reduces blood levels of phosphorus in people with chronic kidney disease who ...
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Ibsrela
Ibsrela (tenapanor) is used for the treatment of irritable bowel syndrome with constipation ...
Auryxia
Auryxia is used for hyperphosphatemia of renal failure, iron deficiency anemia
Velphoro
Velphoro (sucroferric oxyhydroxide) is used to treat hyperphosphatemia in chronic kidney disease ...
Xphozah
Xphozah (tenapanor) is a phosphate absorption inhibitor that is used lower serum phosphorus levels ...
Renagel
Renagel (sevelamer) is used to reduce levels of phosphorus in people with kidney disease who are on ...
Tenapanor
Tenapanor systemic is used for hyperphosphatemia of renal failure, irritable bowel syndrome with ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
